Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 6/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6661818 | 0.88 | HTR6 (0.39) | HTR6KMT2A | |
| SCHEMBL150811 | 0.86 | HTR6 (0.38) | HTR6KMT2ACA1CA2CA5A | |
| SCHEMBL29001803 | 0.84 | ALDH1A1 (0.54) | KMT2ACA1CA2CA12CA7 | |
| SCHEMBL310695 | 0.84 | GAA (0.54) | KMT2ACA1CA2CA12CA7 | |
| SCHEMBL10438578 | 0.84 | PTGS2 (0.40) | HTR6KMT2ACA1CA2ALDH1A1 | |
| SCHEMBL971359 | 0.80 | CA2 (0.46) | KMT2ACA1CA2CA12CA7 | |
| SCHEMBL10438542 | 0.80 | KMT2A (0.44) | KMT2AALDH1A1TDP1SMN1; SMN2GAA | |
| SCHEMBL7672297 | 0.78 | HTR6 (0.48) | HTR6KMT2ACA1CA2CA12 | |
| SCHEMBL8046992 | 0.78 | HTR6 (0.54) | HTR6KMT2AALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL18318350 | 0.75 | HTR6 (0.50) | HTR6KMT2ACA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108117495-B | Spirofluorene ring compound, use thereof, and organic electroluminescent device using the same | 北京鼎材科技有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-104114169-A | Combination of CRTH2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis | ATOPIX THERAPEUTICS LTD | 2014-10-22 | — | — | CN | claimed |
| EP-1538149-B1 | Sulfonium salts as photoinitiators | HENKEL AG & CO KGAA (DE) | 2010-03-17 | — | — | EP | claimed |
| US-20080146627-A1 | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments | LASSAUNIERE PIERRE-ETIENNE CHA | 2008-06-19 | — | — | US | claimed |
| US-7230122-B2 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; photocurable adhesive, coating or sealant compositions | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2007-06-12 | — | — | US | claimed |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | claimed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | claimed |
| US-7029502-B2 | Azo dyes, a process for their preparation and their use in the production of colored plastics or polymeric color particles, and in the dyeing or printing of hydrophobic fiber materials | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-04-18 | — | — | US | claimed |
| EP-1538149-A2 | Sulfonium salts as photoinitiators | National Starch and Chemical Investment Holding Corporation (US) | 2005-06-08 | — | — | EP | claimed |
| US-20050095528-A1 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; photocurable adhesive, coating or sealant compositions | DISPLAY SOURCE ALLIANCE, LLC | 2005-05-05 | — | — | US | claimed |
| EP-0237917-A2 | 1,1-Disubstituted cyclopropane derivatives, processes for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-23 | — | — | EP | claimed |
| EP-0237916-A2 | 1,1-Disubstituted cyclopropane derivatives, processes for their preparation and their use as antimycotics or as intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-23 | — | — | EP | claimed |
| EP-0236913-A2 | Aryl-azolylmethyl-benzocyclo-alkene derivatives, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-16 | — | — | EP | claimed |
| CN-85109721-A | Preparation has the ectoparasite of the no disease homoiothermic animal of control and the method for endoparasite compositions | — | 1987-07-15 | — | — | CN | claimed |
| EP-0211004-A1 | USE OF ACYL UREA COMPOUNDS FOR CONTROLLING ENDOPARASITES AND ECTOPARASITES OF WARM-BLOODED ANIMALS | RHONE-POULENC NEDERLAND B.V. (NL) | 1987-02-25 | — | — | EP | claimed |
| EP-0094038-B1 | 3-AMINO-6-ARYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINES, THEIR PREPARATION AND USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-01-07 | — | — | EP | claimed |
| WO-1986003941-A1 | USE OF ACYL UREA COMPOUNDS FOR CONTROLLING ENDOPARASITES AND ECTOPARASITES OF WARM-BLOODED ANIMALS | UNION CARBIDE CORPORATION (US) | 1986-07-17 | — | — | WO | claimed |
| EP-0121490-A1 | Substituted 6-aryl-1,2,4-triazolo[4,3-b]pyridazines, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-10-10 | — | — | EP | claimed |
| EP-0094038-A1 | 3-Amino-6-aryl-1,2,4-triazolo(4,3-b)pyridazines, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-11-16 | — | — | EP | claimed |
| US-4048153-A | Azo dyes having an optionally substituted 1-azo-3-nitro-4-arylaminophenyl nucleus | SANDOZ LTD. (CH) | 1977-09-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146627-A1 | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments | OXER1, OPRL1, P2RX7 | HTR6 271/4885KMT2A 3430/4885CA1 2677/4885 |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | HTR6 3701/4885KMT2A 2055/4885CA1 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.